Latest Continuous Disclosure News

Ovanti Limited has addressed ASX concerns over its relationship with BNPLPay, clarifying key personnel roles, ownership structures, and cryptocurrency exposure tied to its Licence Agreement.

Wingara AG Limited’s shares have been suspended from ASX trading following a transaction announcement that could alter its core activities. The suspension will last until the company meets key listing rule requirements.

Pact Group Holdings reports a modest 2.7% revenue increase for Q3 FY25, driven by higher volumes and cost savings, while preparing to refinance debt and review its Asian packaging business.

Pact Group Holdings has announced its intention to voluntarily delist from the ASX, citing a concentrated shareholder base, low liquidity, and high regulatory costs. Shareholder approval will be sought at an extraordinary general meeting in June 2025.

OD6 Metals has encountered a regulatory pause in its maiden drilling at the historic Gulf Creek Copper Project, with assay results expected in Q2 2025. Meanwhile, rare earth metallurgical testing at Splinter Rock progresses positively amid a solid cash position.

Bendigo and Adelaide Bank clarifies a modest 5.8% variance in half-year cash earnings against market forecasts, confirming no material surprise and compliance with ASX disclosure rules.

Evion Group NL has announced a pro-rata non-renounceable entitlement issue of over 219 million New Options to raise approximately $659,000. The capital will support key development and feasibility initiatives in Madagascar and India, underscoring the company's strategic growth ambitions amid inherent investment risks.

Cardiex Limited has confirmed to the ASX that it holds no undisclosed information explaining the recent spike in its share price, affirming full compliance with continuous disclosure rules.

EV Resources Limited has responded to ASX inquiries confirming the material impact of China's molybdenum export controls and recent high-grade antimony assay results on its securities.

Future Metals NL has addressed an ASX price query by confirming the release of drilling results from its Eileen Bore Prospect, attributing recent trading activity to investor anticipation and compliance with disclosure rules.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.